LSD-Psychodelics

30 Jul

Posted at 10:13h in LSD-Psychodelics

Psychedelic Substance Notice: Psilocybin, MDMA, and other psychedelic substances are Schedule I controlled substances in the United States and are not FDA-approved for any medical use outside of specific clinical trials. They carry serious risks including psychological distress, heightened vulnerability, and in some cases adverse cardiac or psychiatric events. This article is for informational and educational purposes only and does not constitute medical advice or a recommendation to pursue psychedelic therapy or participate in a clinical trial. Always consult a qualified physician before considering any treatment involving psychoactive substances.

You sign a form. You initial a few boxes. A staff member asks if you have questions, and you say no because you are not sure what to ask yet. That version of consent works fine for a blood draw. It falls apart the moment a study asks you to take a substance that can reshape how you see time, your own memories, and the people in the room. Real consent for this kind of work looks nothing like a signature at a desk.

In a psychedelic research study, informed consent is a conversation that keeps going, not a one-time form. You should learn exactly what the substance may do to your perception and judgment, how long those effects last, what physical touch will and will not happen, and how you can pause or stop. Good clinical trials treat consent as a relationship, and the same standard should guide any serious retreat setting. For broader context on how psychedelic medicine is being studied for addiction and mental health, see this overview of psychedelic medicine explored for addiction and mental health issues.

[caption id="attachment_75327" align="aligncenter" width="500"]psychedelics-choosing-right-provider-pexels.jpg Pexels image[/caption]

28 Jul

Posted at 20:48h in Addiction, LSD-Psychodelics

Addiction Treatment Notice: If you or someone you know is struggling with substance use disorder, help is available. Call the SAMHSA National Helpline at 1-800-662-4357 (free, confidential, 24/7). In an emergency, call 911. Always consult a licensed addiction specialist or physician before beginning, changing, or stopping any addiction treatment program.

Psychedelic Substance Notice: Ibogaine is a Schedule I controlled substance in the United States and is not FDA-approved for any medical use, including addiction treatment. It carries serious and potentially fatal cardiac risks, including QT prolongation and ventricular arrhythmias, and must only be considered under strict medical supervision with full cardiac screening. Deaths have occurred in ibogaine treatment settings. This article is for informational purposes only and does not constitute medical advice or a recommendation to pursue ibogaine therapy. Always consult a qualified physician before considering any treatment involving psychoactive substances.

Addiction treatment needs better options. People are looking past conventional rehab for solutions that deliver deeper psychological healing and faster physical relief. Ibogaine treatment has caught attention for its ability to biologically "reset" the brain's neurochemistry while tackling the emotional roots of addiction. Traditional programs remain important, but knowing how these different approaches stack up is crucial before committing to one path. The right decision depends on your specific needs, medical history, how severe the addiction is, and what your long-term goals look like.

[caption id="attachment_75313" align="aligncenter" width="500"]bogaine-Therapy-vs-Traditional-Addiction-Treatment.jpg Photo by Marek Piwnicki[/caption]

19 May

Posted at 11:00h in Author Interviews, Depression, JAMA, LSD-Psychodelics
Editor's note: This piece discusses mental health issues. If you have experienced suicidal thoughts or have lost someone to suicide and want to seek help, you can contact the Crisis Text Line by texting "START" to 741-741 or call the Suicide Prevention Lifeline at 800-273-8255. [caption id="attachment_73822" align="alignleft" width="200"]Hampus Yngwe, MD, MScCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services Stockholm, Sweden Dr. Hampus Yngwe[/caption] MedicalResearch.com Interview with: Hampus Yngwe, MD, MSc Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services Stockholm, Sweden MedicalResearch.com: What is the background for this study? Response: Depression is a common and disabling condition and current treatments do not work for all patients. Psilocybin has shown promise as a rapid-acting treatment, but more controlled studies are needed to clarify its effects, durability and safety.

01 Apr

Posted at 20:52h in LSD-Psychodelics, Sexual Health
Editor's note: Psychedelics are not FDA approved and may have significant and lasting side effects. Please use caution if you decide to use them. Psychedelics should not be used during pregnancy or around children. MedicalResearch.com is not endorsing the use of psychedelics for any reason at this time. MedicalResearch.com Interview with: [caption id="attachment_67728" align="alignleft" width="200"]Daniel J. Kruger, PhDResearch Associate Professor Research Scientist Psychology, Public Health Jacobs School of Medicine and Biomedical Sciences University at Buffalo, State University of New York Dr. Kruger[/caption] Daniel J. Kruger, PhD Research Associate Professor Research Scientist Psychology, Public Health Jacobs School of Medicine and Biomedical Sciences University at Buffalo, State University of New York MedicalResearch.com: What is the background for this study? Response: There is a lot of excitement about psychedelics now, including a boom in research. Most of the investment is in therapeutic applications, as studies are showing amazing results for treating conditions like depression and PTSD. These are worthy pursuits, of course, though we think there is so much more to explore. There are so many areas that have not yet been covered. For example, Timothy Leary said that psychedelics were great for sex. He probably knew this would get people’s attention. How prevalent is this really in people’s experiences?